Review




Structured Review

STEMCELL Technologies Inc stemdiff astrocyte differentiation kit
Stemdiff Astrocyte Differentiation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stemdiff astrocyte differentiation kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
stemdiff astrocyte differentiation kit - by Bioz Stars, 2026-03
90/100 stars

Images



Similar Products

90
STEMCELL Technologies Inc stemdiff astrocyte differentiation kit
Stemdiff Astrocyte Differentiation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stemdiff astrocyte differentiation kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
stemdiff astrocyte differentiation kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc stemdiff tm astrocyte differentiation kit
Stemdiff Tm Astrocyte Differentiation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stemdiff tm astrocyte differentiation kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
stemdiff tm astrocyte differentiation kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc astrocyte differentiation medium (stemdiff astrocytetm differentiation kit #100-0013)
Astrocyte Differentiation Medium (Stemdiff Astrocytetm Differentiation Kit #100 0013), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/astrocyte differentiation medium (stemdiff astrocytetm differentiation kit #100-0013)/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
astrocyte differentiation medium (stemdiff astrocytetm differentiation kit #100-0013) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc stemdiff astrocyte differentiation kit #100-0013
Stemdiff Astrocyte Differentiation Kit #100 0013, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stemdiff astrocyte differentiation kit #100-0013/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
stemdiff astrocyte differentiation kit #100-0013 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc stemdiff tm astrocyte differentiation kit #100-0013
Characterisation of ‘healthy’ iPSC‐derived astrocytes. (a) Representative images showing differentiation and ICC staining of iPSC‐derived astrocytic cells at Day 45+. The astrocytes were differentiated from ‘healthy’ control NPCs for >40 days using astrocytes differentiation and <t>maturation</t> protocols. Top) Phase contrast images of control astrocytes on Days 2, 10 and 40 in culture post differentiation. Bottom) Cells were stained using immunofluorescent antibodies for astrocytic markers ALDH1L1 (left, green), S100β (middle, green) and GFAP (right, red), nuclei were counterstained in each image with DAPI (blue). Scale bars: 100 μM. (b) Cellular glycogen content of control astrocytes following exposure to hypoglycaemic conditions and treatment with DAB over 60 and 120 min. (c) Glycogen content of cells treated with dbcAMP an isoproterenol. (d) Glycogen contents of cells treated with Glutamate, oubain, glutamate and ouabain, TBOA and glutamate and TBOA for 60, 180 and 360 min. Results are expressed as ug/mg protein ± SD, n = 3 p < 0.05 (*), p < 0.01 (**), p < 0.001 (***). For DAB (b), a two‐way analysis of variance (ANOVA) was performed follow by Sidaks post‐test. Comparisons between treatments (c) were performed using analysis of variance (ANOVA) followed by Dunnet's post‐test. Each replicate or ‘ n ’ represents an independent culture preparation and is displayed as an individual data point.
Stemdiff Tm Astrocyte Differentiation Kit #100 0013, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stemdiff tm astrocyte differentiation kit #100-0013/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
stemdiff tm astrocyte differentiation kit #100-0013 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc stemdiff astrocytes differentiation kit
Characterisation of ‘healthy’ iPSC‐derived astrocytes. (a) Representative images showing differentiation and ICC staining of iPSC‐derived astrocytic cells at Day 45+. The astrocytes were differentiated from ‘healthy’ control NPCs for >40 days using astrocytes differentiation and <t>maturation</t> protocols. Top) Phase contrast images of control astrocytes on Days 2, 10 and 40 in culture post differentiation. Bottom) Cells were stained using immunofluorescent antibodies for astrocytic markers ALDH1L1 (left, green), S100β (middle, green) and GFAP (right, red), nuclei were counterstained in each image with DAPI (blue). Scale bars: 100 μM. (b) Cellular glycogen content of control astrocytes following exposure to hypoglycaemic conditions and treatment with DAB over 60 and 120 min. (c) Glycogen content of cells treated with dbcAMP an isoproterenol. (d) Glycogen contents of cells treated with Glutamate, oubain, glutamate and ouabain, TBOA and glutamate and TBOA for 60, 180 and 360 min. Results are expressed as ug/mg protein ± SD, n = 3 p < 0.05 (*), p < 0.01 (**), p < 0.001 (***). For DAB (b), a two‐way analysis of variance (ANOVA) was performed follow by Sidaks post‐test. Comparisons between treatments (c) were performed using analysis of variance (ANOVA) followed by Dunnet's post‐test. Each replicate or ‘ n ’ represents an independent culture preparation and is displayed as an individual data point.
Stemdiff Astrocytes Differentiation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stemdiff astrocytes differentiation kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
stemdiff astrocytes differentiation kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc stemdiff™ astrocyte differentiation kit
Characterisation of ‘healthy’ iPSC‐derived astrocytes. (a) Representative images showing differentiation and ICC staining of iPSC‐derived astrocytic cells at Day 45+. The astrocytes were differentiated from ‘healthy’ control NPCs for >40 days using astrocytes differentiation and <t>maturation</t> protocols. Top) Phase contrast images of control astrocytes on Days 2, 10 and 40 in culture post differentiation. Bottom) Cells were stained using immunofluorescent antibodies for astrocytic markers ALDH1L1 (left, green), S100β (middle, green) and GFAP (right, red), nuclei were counterstained in each image with DAPI (blue). Scale bars: 100 μM. (b) Cellular glycogen content of control astrocytes following exposure to hypoglycaemic conditions and treatment with DAB over 60 and 120 min. (c) Glycogen content of cells treated with dbcAMP an isoproterenol. (d) Glycogen contents of cells treated with Glutamate, oubain, glutamate and ouabain, TBOA and glutamate and TBOA for 60, 180 and 360 min. Results are expressed as ug/mg protein ± SD, n = 3 p < 0.05 (*), p < 0.01 (**), p < 0.001 (***). For DAB (b), a two‐way analysis of variance (ANOVA) was performed follow by Sidaks post‐test. Comparisons between treatments (c) were performed using analysis of variance (ANOVA) followed by Dunnet's post‐test. Each replicate or ‘ n ’ represents an independent culture preparation and is displayed as an individual data point.
Stemdiff™ Astrocyte Differentiation Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stemdiff™ astrocyte differentiation kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
stemdiff™ astrocyte differentiation kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Characterisation of ‘healthy’ iPSC‐derived astrocytes. (a) Representative images showing differentiation and ICC staining of iPSC‐derived astrocytic cells at Day 45+. The astrocytes were differentiated from ‘healthy’ control NPCs for >40 days using astrocytes differentiation and maturation protocols. Top) Phase contrast images of control astrocytes on Days 2, 10 and 40 in culture post differentiation. Bottom) Cells were stained using immunofluorescent antibodies for astrocytic markers ALDH1L1 (left, green), S100β (middle, green) and GFAP (right, red), nuclei were counterstained in each image with DAPI (blue). Scale bars: 100 μM. (b) Cellular glycogen content of control astrocytes following exposure to hypoglycaemic conditions and treatment with DAB over 60 and 120 min. (c) Glycogen content of cells treated with dbcAMP an isoproterenol. (d) Glycogen contents of cells treated with Glutamate, oubain, glutamate and ouabain, TBOA and glutamate and TBOA for 60, 180 and 360 min. Results are expressed as ug/mg protein ± SD, n = 3 p < 0.05 (*), p < 0.01 (**), p < 0.001 (***). For DAB (b), a two‐way analysis of variance (ANOVA) was performed follow by Sidaks post‐test. Comparisons between treatments (c) were performed using analysis of variance (ANOVA) followed by Dunnet's post‐test. Each replicate or ‘ n ’ represents an independent culture preparation and is displayed as an individual data point.

Journal: Journal of Neurochemistry

Article Title: Altered metabolic function induced by Aβ‐oligomers and PSEN1 mutations in iPSC ‐derived astrocytes

doi: 10.1111/jnc.16267

Figure Lengend Snippet: Characterisation of ‘healthy’ iPSC‐derived astrocytes. (a) Representative images showing differentiation and ICC staining of iPSC‐derived astrocytic cells at Day 45+. The astrocytes were differentiated from ‘healthy’ control NPCs for >40 days using astrocytes differentiation and maturation protocols. Top) Phase contrast images of control astrocytes on Days 2, 10 and 40 in culture post differentiation. Bottom) Cells were stained using immunofluorescent antibodies for astrocytic markers ALDH1L1 (left, green), S100β (middle, green) and GFAP (right, red), nuclei were counterstained in each image with DAPI (blue). Scale bars: 100 μM. (b) Cellular glycogen content of control astrocytes following exposure to hypoglycaemic conditions and treatment with DAB over 60 and 120 min. (c) Glycogen content of cells treated with dbcAMP an isoproterenol. (d) Glycogen contents of cells treated with Glutamate, oubain, glutamate and ouabain, TBOA and glutamate and TBOA for 60, 180 and 360 min. Results are expressed as ug/mg protein ± SD, n = 3 p < 0.05 (*), p < 0.01 (**), p < 0.001 (***). For DAB (b), a two‐way analysis of variance (ANOVA) was performed follow by Sidaks post‐test. Comparisons between treatments (c) were performed using analysis of variance (ANOVA) followed by Dunnet's post‐test. Each replicate or ‘ n ’ represents an independent culture preparation and is displayed as an individual data point.

Article Snippet: Cells were plated at 5 × 10 4 /cm 2 density and maintained in a 37°C, 5% CO 2 / 95% air atmosphere with a total medium exchange every other day, through two subsequent passages, before switching to astrocyte maturation medium (STEMdiff tm Astrocyte maturation kit #100‐0016, StemCell Technologies, Cambridge, UK).

Techniques: Derivative Assay, Staining, Control